COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 1052: Articles 10511-10520  | Next

Lineage replacement and evolution captured by the United Kingdom Covid Infection Survey
Lythgoe, K. A., Golubchik, T., Hall, M., House, T., MacIntyre-Cockett, G., Fryer, H., Thomson, L., Nurtay, A., Buck, D., Green, A., Trebes, A., Piazza, P., Lonie, L. J., Studley, R., Rourke, E., Cook, D., Smith, D., Bashton, M., Nelson, A., Crown, M., McCann, C., Young, G. R., de Santos, R. A. N., Richards, Z., Tariq, A., Wellcome Sanger Institute COVID-19 Surveillance Team, , COVID-19 Infection Survey Group, , The COVID-19 Genomics UK (COG-UK) consortium, , Fraser, C., Diamond, I., Barrett, J., Walker, S., Bonsall, D.
10.1101/2022.01.05.21268323 — Posted: 2022-01-06
Cell-mediated and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients
Yang, L. M., Costales, C., Ramanathan, M., Bulterys, P. L., Murugesan, K., Schroers-Martin, J., Alizadeh, A. A., Boyd, S. D., Brown, J. M., Nadeau, K. C., Nadimpalli, S. S., Wang, A. X., Busque, S., Pinsky, B. A., Banaei, N.
10.1101/2022.01.04.22268750 — Posted: 2022-01-05
Narrowing gap in regional and age-specific excess mortality in the first year and a half of COVID-19 in Hungary
Toth, C. G.
10.1101/2022.01.05.22268786 — Posted: 2022-01-05
Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-months
Medigeshi, G. R., Batra, G., Murugesan, D. R., Thiruvengadam, R., Chattopadhyay, S., Das, B., Gosain, M., Ayushi, , Singh, J., Anbalagan, A., Shaman, H., Pargai, K., Mehdi, F., Das, S. J., Kahlon, N., Singh, S., Kshetrapal, P., Wadhwa, N., Pandey, A. K., Bhatnagar, S., Garg, P. K.
10.1101/2022.01.04.22268747 — Posted: 2022-01-05
Timing of Breakthrough Infection Risk After Vaccination Against SARS-CoV-2
Tuite, A., Lee, N., Fisman, D.
10.1101/2022.01.04.22268773 — Posted: 2022-01-05
SARS-CoV-2 Genetic diversity and lineage dynamics of in Egypt
Roshdy, W. H., Khalifa, M. K., San, J. E., Tegally, H., Wilkinson, E., Showky, S., Martin, D. P., Moir, M., Naguib, A., Elguindy, N., Gomaa, M. R., Fahim, M., Elsood, H. A., Mohsen, A. A., Galal, R., Hassany, M., Lessells, R. J., Al Karmalawy, A. A., EL Shesheny, R., Kandeil, A. M., Ali, M. A., de Oliveira, T.
10.1101/2022.01.05.22268646 — Posted: 2022-01-05
Personal Resilience, Social Support, and Organizational Support Impact Burnout among Nurses During COVID-19
Daghash, H.
10.1101/2022.01.05.22268637 — Posted: 2022-01-05
Exploring the impact of shielding advice on the health and wellbeing of individuals identified as extremely vulnerable and advised to shield in Southwest England amid the COVID-19 pandemic: A mixed-methods evaluation
Lasseter, G., Compston, P., Robin, C., Lambert, H., Hickman, M., Denford, S., Reynolds, R., Zhang, J., Cai, S., Zhang, T., Smith, L. E., Rubin, J., Yardley, L., Amlot, R., Oliver, I.
10.1101/2022.01.05.21268251 — Posted: 2022-01-05
Development of the one-step qualitative RT-PCR assay to detect SARS-CoV-2 Omicron (B.1.1.529) variant in respiratory specimens
Phan, T., Boes, S., McCullough, M., Gribschaw, J., Wells, A.
10.1101/2022.01.04.22268772 — Posted: 2022-01-05
Meta-analysis of COVID-19 patients to understand the key predictors of mortality in the non-vaccinated groups in remote settings
Jain, N. L., Parekh, K., Saigal, R., Alyusuf, A., Kelly, G., Jha, A.
10.1101/2022.01.04.21267659 — Posted: 2022-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).